Sylvia Adams

ORCID: 0000-0003-4737-1952

Also affiliated with The University of Texas at San Antonio, New York University

MedicineImmunology and MicrobiologyBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 18 papers. Top paper: “The tale of TILs in breast cancer: A report from The International Immuno-Oncology Biomarker Working Group”.

The tale of TILs in breast cancer: A report from The International Immuno-Oncology Biomarker Working Group

npj Breast Cancer(2021)10.1038/s41523-021-00346-1

N/A

4.9DataRank · unranked

281 citations

Harry R. Haynes, Elizabeth F. Blackley, Susan Fineberg, Jeffrey Shear, Sophia Turner +73 more

A Multicenter Phase II Trial of Ipilimumab and Nivolumab in Unresectable or Metastatic Metaplastic Breast Cancer: Cohort 36 of Dual Anti–CTLA-4 and Anti–PD-1 Blockade in Rare Tumors (DART, SWOG S1609)

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-21-2182

N/A

3.8DataRank · unranked

125 citations

Megan Othus, Sandip Pravin Patel, Kathy D. Miller, Rashmi Chugh, Scott M. Schuetze +23 more

Report on computational assessment of Tumor Infiltrating Lymphocytes from the International Immuno-Oncology Biomarker Working Group

npj Breast Cancer(2020)10.1038/s41523-020-0154-2

N/A

3.5DataRank · unranked

168 citations

Elisabeth Specht Stovgaard, Eva Balslev, Jeppe Thagaard, Weijie Chen, Sarah Dudgeon +95 more

Pitfalls in assessing stromal tumor infiltrating lymphocytes (sTILs) in breast cancer

npj Breast Cancer(2020)10.1038/s41523-020-0156-0

N/A

0.801DataRank · unranked

208 citations

Elvire Roblin, Rim S. Kim, Stefan Michiels, Brandon D. Gallas, Weijie Chen +95 more

Immune resilience despite inflammatory stress promotes longevity and favorable health outcomes including resistance to infection

Nature Communications(2023)10.1038/s41467-023-38238-6

N/A

0.689DataRank · unranked

98 citations

Muthu Saravanan Manoharan, Grace C. Lee, Lyle R. McKinnon, Justin A. Meunier, Maristella Steri +95 more

Immunologic resilience and COVID-19 survival advantage

Journal of Allergy and Clinical Immunology(2021)10.1016/j.jaci.2021.08.021

N/A

0.578DataRank · unranked

46 citations

Marcos I. Restrepo, Nathan Harper, Muthu Saravanan Manoharan, Alisha M. Smith, Justin A. Meunier +95 more

Dual anti-CTLA-4 and anti-PD-1 blockade in metaplastic carcinoma of the breast: Dart (SWOG S1609, Cohort 36).

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.1073

N/A

0.524DataRank · unranked

32 citations

Megan Othus, Sandip Pravin Patel, Young Kwang Chae, Kathy D. Miller, Rashmi Chugh +8 more

Ontogeny and Vulnerabilities of Drug-Tolerant Persisters in HER2+ Breast Cancer

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.08.28.273029

N/A

0.448DataRank · unranked

14 citations

Jayu Jen, Shaowen Jiang, Azin Sayad, Arvind Singh Mer, Kevin R. Brown +19 more

Image‐based multiplex immune profiling of cancer tissues: translational implications. A report of the International Immuno‐oncology Biomarker Working Group on Breast Cancer

The Journal of Pathology(2024)10.1002/path.6238

N/A

0.425DataRank · unranked

16 citations

David B. Page, Glenn Broeckx, Claudia Aura Gonzalez, Caoimbhe Burke, Clodagh Murphy +95 more

Evaluation of the gut microbiome and sex hormones in postmenopausal women with newly diagnosed hormone receptor-positive breast cancer versus healthy women: a prospective case-control study

Journal of Cancer Research and Clinical Oncology(2025)10.1007/s00432-025-06338-z

N/A

0.392DataRank · unranked

10 citations

Grant Hussey, Yelena Novik, Adrian A. Franke, Angelina Volkova, Karina Martínez‐Flores +11 more

Common Genetic Polymorphisms Influence Blood Biomarker Measurements in COPD

UNC Libraries(2020)10.17615/zh9p-qj70

N/A

0.347DataRank · unranked

6 citations

Irene Swift, Adel El-Bouiez, Joel L. Weissfeld, Elizabeth Guy, Tanya Mann +91 more

Peritumoral macrophages recruit eosinophils to promote antitumor immune responses in breast cancer

Proceedings of the National Academy of Sciences(2025)10.1073/pnas.2504645122

N/A

0DataRank · unranked

5 citations

Eduardo Esteva, Janet Ofelia Guevara Canales, Oriana A. Perez, Anna Eichinger, William Huntley +6 more

Activating a collaborative innate-adaptive immune response to control metastasis

Cancer Cell(2021)10.1016/j.ccell.2021.08.005

N/A

0DataRank · unranked

281 citations

Tim Kees, Ana S. Almeida, Bodu Liu, Xue‐Yan He, David Ng +7 more

Data from A Multicenter Phase II Trial of Ipilimumab and Nivolumab in Unresectable or Metastatic Metaplastic Breast Cancer: Cohort 36 of Dual Anti–CTLA-4 and Anti–PD-1 Blockade in Rare Tumors (DART, SWOG S1609)

10.1158/1078-0432.c.6530837.v1

N/A

0DataRank · unranked

0 citations

Megan Othus, Sandip Pravin Patel, Kathy D. Miller, Rashmi Chugh, Scott M. Schuetze +23 more

Multinuclear MRI to disentangle intracellular sodium concentration and extracellular volume fraction in breast cancer

Scientific Reports(2021)10.1038/s41598-021-84616-9

N/A

0DataRank · unranked

30 citations

Linda Moy, Justin Fogarty, Freya Schnabel, Sylvia Adams, Deborah Axelrod +4 more

Hyperactive CDK2 Activity in Basal-like Breast Cancer Imposes a Genome Integrity Liability that Can Be Exploited by Targeting DNA Polymerase ε

Molecular Cell(2020)10.1016/j.molcel.2020.10.016

N/A

0DataRank · unranked

58 citations

Lili M. Blumenberg, Elizabeth Gorodetsky, Triantafyllia Karakousi, Nicole Hirsh, Samantha Alvarez +12 more

Data from A Multicenter Phase II Trial of Ipilimumab and Nivolumab in Unresectable or Metastatic Metaplastic Breast Cancer: Cohort 36 of Dual Anti–CTLA-4 and Anti–PD-1 Blockade in Rare Tumors (DART, SWOG S1609)

(2023)10.1158/1078-0432.c.6530837

N/A

0DataRank · unranked

0 citations

Megan Othus, Sandip Pravin Patel, Kathy D. Miller, Rashmi Chugh, Scott M. Schuetze +23 more

Serial single-cell profiling analysis of metastatic TNBC during Nab-paclitaxel and pembrolizumab treatment

UNC Libraries(2024)10.17615/w0ps-zx64

N/A

0DataRank · unranked

0 citations

Sylvia Adams, Ece Bagdatlioglu, Jianping Deng, Natalie Klar, Adriana Heguy +10 more